Hansa Biopharma AB (publ) (STO:HNSA)
Sweden · Delayed Price · Currency is SEK 38.38
-0.96 (-2.44%)
Nov 2, 2026, 4:29 PM CET
Hansa Biopharma AB Market Cap
Hansa Biopharma AB has a market cap or net worth of 3.91 billion as of November 2, 2026. It is the 15,760th most valuable company in the world and the 203rd biggest in Sweden. Its market cap has increased by 23.01% in one year.
Market Cap
3.91B
Enterprise Value
4.39B
Revenue
189.46M
Global Rank
Country Rank
#203 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since April 24, 2008, Hansa Biopharma AB's market cap has increased from 30.71M to 3.91B, an increase of 12,616.96%. That is a compound annual growth rate of 29.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 3.91B | 11.70% |
| Dec 30, 2025 | 3.50B | 31.53% |
| Dec 30, 2024 | 2.66B | 93.47% |
| Dec 29, 2023 | 1.37B | -46.77% |
| Dec 30, 2022 | 2.58B | -34.64% |
| Dec 30, 2021 | 3.95B | -63.06% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioArctic AB | 28.14B |
| Egetis Therapeutics AB | 4.68B |
| Vicore Pharma Holding AB | 2.73B |
| Saniona AB | 1.54B |
| Genovis AB (publ.) | 1.46B |
| Flerie AB | 1.21B |
| Medivir AB | 967.26M |
| SynAct Pharma AB | 908.29M |